Our Scientific Advisory Board

Dr Waddell has over 40 years’ experience in the pharmaceutical R&D sector and has worked in a variety of drug discovery settings. He has held various leadership positions at AstraZeneca over a period of almost 20 years. Other key positions held by Ian include head of biology in the Drug Discovery Unit at the Cancer Research UK Manchester Institute, and Chief Scientific Officer of early discovery at the global Contract Research Organisation Charles River laboratories. Dr Waddell has also acted as the Chief Scientific Officer at CUMULUS Oncology and the Chief Executive Officer at the Cumulus spin out Nodus Oncology. Ian is currently the director of his own scientific consultancy company 25IDW Ltd and holds two board level positions with listed companies, firstly as the Executive Chair of Concept Life Sciences and as a non-executive director of the human tumour bioprinting start up Carcinotech.

Ian is a biochemist by training with extensive expertise in Diabetes and Obesity, however an interest in the metabolic aspects of Cachexia lead to him switching to Oncology focused drug discovery in 2005. He has a BSc in Biochemistry and a and PhD in Molecular Medicine.  Following post doc experience, he spent 5 years as a lecturer in Molecular Medicine in the Department of Child Health at Ninewells’s Hospital and Medical School before joining Zeneca in 1993.